The Norwegian Registry of Persons Assessed for Cognitive Symptoms in Specialist Health Care Services (NorCog)
Trajectories in real life and risk factors of dementia (Trail-Dem)
Importance of low-grade inflammation in patients with cognitive impairment due to Alzheimer’s disease and stroke (Inflamdem)
Qualitative EEG as a prognostic tool in mild cognitive impairment (NORD-MCI)
Disentangle subtypes of Alzheimer’s disease using structural MRI modalities- a cross-sectional and longitudinal study (SAS-MRI study)
Spatial orientation in persons with mild cognitive impairment and Alzheimer’s disease
Repeated advanced cognitive training in mild cognitive impairment (REACT-MCI)
Mechanisms of increased susceptibility to Alzheimer’s disease in women – FEMDEM
The crosstalk of mitochondrial dysfunction, inflammation, and genotypes in the insidious onset of neurodegenerative dementia disorders (MITO-DEM)
Improving dementia diagnostics in clinical practice using artificial intelligence (AIDDEM)
Neutrophil extracellular traps (NETs) in Alzheimer’s disease: deciphering pathophysiology in the search for novel biomarkers and treatment targets.
The Norwegian cognitive impairment after stroke study (Nor-COAST)
Clinical trials (2023-2026)
REACT-MCI - repeated advanced cognitive training in mild cognitive impairment. In REACT-MCI we study whether advanced memory training can improve memory and quality of life in patients with mild cognitive impairment (MCI). For more information, see the study webpage (in Norwegian)
The ANeED study – ambroxol in new and early dementia with Lewy bodies (DLB). In the ANeED clinical trial we investigate if the mediciation ambroxol has a treatment effect for cognitive impairment or dementia caused by Lewy body disease. Included patients have to be at an early disease stage. For more information, see the study webpage at Helse Fonna (in Norwegian)
Edwin TH, Håberg AK, Zotcheva E, Bratsberg B, Jugessur A, Engdahl B, Bowen C, Selbæk G, Kohler HP, Harris JR, Tom SE, Krokstad S, Mekonnen T, Stern Y, Skirbekk VF, Strand BH(2024) Trajectories of Occupational Cognitive Demands and Risk of Mild Cognitive Impairment and Dementia in Later Life: The HUNT4 70+ Study Neurology, 102(9), e209353 DOI 10.1212/WNL.0000000000209353, PubMed 38630959
Persson K, Barca ML, Edwin TH, Cavallin-Eklund L, Tangen GG, Rhodius-Meester HFM, Selbæk G, Knapskog AB, Engedal K(2024) Regional MRI volumetry using NeuroQuant versus visual rating scales in patients with cognitive impairment and dementia Brain Behav, 14(2), e3397 DOI 10.1002/brb3.3397, PubMed 38600026
Sandvig HV, Aam S, Alme KN, Lydersen S, Magne Ueland P, Ulvik A, Wethal T, Saltvedt I, Knapskog AB(2024) Neopterin, kynurenine metabolites, and indexes related to vitamin B6 are associated with post-stroke cognitive impairment: The Nor-COAST study Brain Behav Immun, 118, 167-177 DOI 10.1016/j.bbi.2024.02.030, PubMed 38428649